ANAPTYSBIO, INC (ANAB) insider trading

By person

12 insiders · 42 transactions

35.0×

Daniel Faga holds 35.0 times base salary in stock. $24.74M of shares against $706.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Faga last reported holding, valued at $49.87, the price Common Stock was last bought or sold at on the open market here, on 1 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daniel Faga

President, CEO

—

$2.81M (13)

−$2.81M

495,965

1.66%

$24.74M

+22.3%

Eric J Loumeau

Chief Legal Officer

—

$2.74M (12) scheduled

−$2.74M

12,835

0.0429%

$640.14K

+172.7%

Dennis Mulroy

Chief Financial Officer

—

$1.55M (6) scheduled

−$1.55M

21,852

0.0731%

$1.09M

+210.0%

John P. Schmid

Director

—

$1.16M (3)

−$1.16M

37,652

0.1259%

$1.88M

+865.4%

Magda Marquet

Director

—

$530.53K (2) scheduled

−$530.53K

9,930

0.0332%

$495.25K

+154.6%

Paul F. Lizzul

Chief Medical Officer

—

$521.53K (4)

−$521.53K

42,088

0.1408%

$2.10M

+149.6%

Hollings Renton

Director

—

$249.37K (1) scheduled

−$249.37K

10,995

0.0368%

$548.37K

+463.8%

J. Anthony Ware

Director

—

$193.34K (1)

−$193.34K

9,630

0.0322%

$480.29K

+28.4%

EcoR1 Capital, LLC entity

Director

—

7,880,094

26.36%

$393.01M

+1.1%

John A Orwin

Director

—

17,995

0.0602%

$897.49K

+439.6%

Rita Jain

Director

—

11,864

0.0397%

$591.71K

+161.7%

Dennis M Fenton

Director

—

4,965

0.0166%

$247.63K

+154.6%

ANAPTYSBIO, INC

What the insiders did Net selling

By person